Teva Pharmaceutical Industries reported $216M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Cipla INR 131.3M 9M Mar/2026
Dr.Reddys Laboratories INR 1.06B 113M Mar/2026
Guangzhou Baiy CNY 102.39M 780K Jun/2025
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kalbe Farma IDR 9.69B 689.63M Sep/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Teva Pharmaceutical Industries USD 216M 4M Mar/2026